DANIEL BRENNAN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL BRENNAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL BRENNAN. DANIEL BRENNAN is a Chief Commercial Officer in CATALYST PHARMACEUTICALS, INC. ($CPRX) and a Chief Operating Officer in Edge Therapeutics, Inc. ($EDGE) and a Exec VP & Chf Operations Off. in Insys Therapeutics, Inc. ($INSY).
Address: C/O INSYS THERAPEUTICS, INC. 1333 SO. SPECTRUM BLVD. # 100 CHANDLER 85286 AZ
Companies in which DANIEL BRENNAN is an Insider
CATALYST PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL BRENNAN: Chief Commercial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 04 2019
$CPRX Market Capitalization: $92.81M
$CPRX Previous Close: $1.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Insys Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL BRENNAN: Exec VP & Chf Operations Off.
Holdings: 1 shares
Current Value: $10
Latest Transaction: Aug 09 2016
$INSY Market Capitalization: $694.73M
$INSY Previous Close: $9.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDS Biotechnology Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL BRENNAN: Chief Operating Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 05 2018
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DANIEL BRENNAN
Sentiment: All, CPRX, INSY, EDGE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 0.00 | 44,000 | 0 | 691,000 | |
| Dec 04 2019 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 4.64 | 132,000 | 612,480 | 647,000 | |
| Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 2.24 | 38,334 | 85,868 | 515,000 | |
| Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 2.24 | 38,333 | 85,866 | 476,666 | |
| Dec 21 2018 | CPRX | CATALYST PHARMACEU ... | BRENNAN DANIEL | Chief Commercial Of ... | Option Exercise | A | 2.24 | 38,333 | 85,866 | 438,333 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | BRENNAN DANIEL | Chief Operating Off ... | Option Exercise | A | 14.98 | 90,000 | 1,348,200 | 90,000 | |
| Nov 02 2016 | EDGE | Edge Therapeutics, ... | BRENNAN DANIEL | Chief Operating Off ... | Option Exercise | A | 10.09 | 150,000 | 1,513,500 | 150,000 |